DC60564 · Updated 27 October 2026
Lipid GVS-18-B6
Instructions for Use
Before use
Check the supplied lot number, batch COA, approved SDS, quantity and retest date. Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light.
For small quantities of viscous or oily lipid, volumetric transfer can reduce weighing losses. Confirm solvent compatibility and solubility before preparing a stock; calculated volumes do not establish solubility.
Stock-solution planning
Volume (mL) = mass (mg) × 1000 / [molecular weight × concentration (mM)].
| Mass | 10 mM | 20 mM |
|---|---|---|
| 10 mg | 1.6834 mL | 0.8417 mL |
| 25 mg | 4.2084 mL | 2.1042 mL |
| 50 mg | 8.4168 mL | 4.2084 mL |
| 100 mg | 16.8336 mL | 8.4168 mL |
Literature formulation reference
| Component | DC Chemicals product | Molecular weight | Molar ratio | Mass at 1 µmol total lipid (mg) |
|---|---|---|---|---|
| GVS-18-B6 | DC60564 | 594.05 | 54.6 | Not calculable from disclosed data |
| DSPC | DC57005 | 790.15 | 10.9 | Not calculable from disclosed data |
| Cholesterol | DCD-041 | 386.65 | 32.8 | Not calculable from disclosed data |
| mPEG-DMA | Not uniquely mapped | Not established | 1.6 | Not calculable from disclosed data |
The nominal ratio is from Materials and Methods, LNP Production, in the order GVS-18-B6:DSPC:cholesterol:PEG lipid. Its rounded total is 99.9. SI Table S2 identifies mPEG-DMA and separately reports pre- and post-formulation measurements. PEG molecular weight and exact catalog mapping remain unassigned, so a complete mass conversion is not prefilled. The low-PEG hemolysis formulation is a separate experiment. No N/P value is inferred.
Read the complete study conditions, biological results, tolerability and figures →
References
- Holland R, Lam K, Jeng S, et al. Silicon Ether Ionizable Lipids Enable Potent mRNA Lipid Nanoparticles with Rapid Tissue Clearance. ACS Nano. 2024;18:10374–10387. DOI: 10.1021/acsnano.3c09028. Table 1; Figures 2–7; Materials and Methods.
- Supporting Information, nn3c09028_si_001.pdf. Table S2 (mPEG-DMA and measured composition); Figure S3 (hemolysis); Figure S4 (protein corona).
